<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T23:10:54Z</responseDate>
  <request identifier="oai:figshare.com:article/33814936" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33814936</identifier>
        <datestamp>2026-09-15T18:02:56Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_811</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Summary of clinical and demographic characteristics of patients with RR-TB who had a drug susceptibility testing (DST) result for FQ resistance in our dataset.&lt;/p&gt;</dc:title>
          <dc:creator>Tianfang Shao (16843152)</dc:creator>
          <dc:creator>Mariana R. Neves (24950380)</dc:creator>
          <dc:creator>Molly Franke (488283)</dc:creator>
          <dc:creator>Carole Mitnick (4615363)</dc:creator>
          <dc:creator>Jennifer Furin (435179)</dc:creator>
          <dc:creator>Ted Cohen (118302)</dc:creator>
          <dc:creator>Reza Yaesoubi (207900)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Mathematical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>xlink "&gt; fluoroquinolones</dc:subject>
          <dc:subject>world health organization</dc:subject>
          <dc:subject>support clinical decision</dc:subject>
          <dc:subject>shorter regimens endorsed</dc:subject>
          <dc:subject>sharing platform curated</dc:subject>
          <dc:subject>patient characteristics observable</dc:subject>
          <dc:subject>including case definition</dc:subject>
          <dc:subject>employment variables showed</dc:subject>
          <dc:subject>pooled models &lt;/</dc:subject>
          <dc:subject>external data could</dc:subject>
          <dc:subject>consistently informative predictors</dc:subject>
          <dc:subject>country models &lt;/</dc:subject>
          <dc:subject>several countries cannot</dc:subject>
          <dc:subject>developed prediction models</dc:subject>
          <dc:subject>fluoroquinolones among patients</dc:subject>
          <dc:subject>auprc reaching 0</dc:subject>
          <dc:subject>prediction models</dc:subject>
          <dc:subject>models developed</dc:subject>
          <dc:subject>related variables</dc:subject>
          <dc:subject>country data</dc:subject>
          <dc:subject>typically developed</dc:subject>
          <dc:subject>auprc ranging</dc:subject>
          <dc:subject>auprc ).</dc:subject>
          <dc:subject>used data</dc:subject>
          <dc:subject>access data</dc:subject>
          <dc:subject>single country</dc:subject>
          <dc:subject>whereas demographic</dc:subject>
          <dc:subject>three strategies</dc:subject>
          <dc:subject>results submitted</dc:subject>
          <dc:subject>results may</dc:subject>
          <dc:subject>relatively stable</dc:subject>
          <dc:subject>recall curve</dc:subject>
          <dc:subject>rapid testing</dc:subject>
          <dc:subject>neural networks</dc:subject>
          <dc:subject>national institute</dc:subject>
          <dc:subject>model discrimination</dc:subject>
          <dc:subject>marked changes</dc:subject>
          <dc:subject>limited set</dc:subject>
          <dc:subject>infectious diseases</dc:subject>
          <dc:subject>findings highlight</dc:subject>
          <dc:subject>externally validated</dc:subject>
          <dc:subject>corrected discrimination</dc:subject>
          <dc:subject>analysis dataset</dc:subject>
          <dc:subject>175 patients</dc:subject>
          <dc:description>&lt;p&gt;Summary of clinical and demographic characteristics of patients with RR-TB who had a drug susceptibility testing (DST) result for FQ resistance in our dataset.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T18:05:18Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pmed.1004965.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Summary_of_clinical_and_demographic_characteristics_of_patients_with_RR-TB_who_had_a_drug_susceptibility_testing_DST_result_for_FQ_resistance_in_our_dataset_p_/33814936</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
